SenoBright offers clinicians a new tool to help detect and diagnose breast cancer rapidly and accurately, even in the densest part of the breast. This technology enables physicians to perform additional tests faster, see the results in a familiar context, and make diagnostic decisions more confidently by providing a contrast-enhanced image in exactly the same position as the standard mammography views.
Click on the video below to hear Dr. Kristi Funk, founder and breast surgeon of PLBC, Dr. Lesley Taylor, breast surgeon of PLBC, and Diana Franklin, breast cancer survivor and operations manager at PLBC, discuss the value of this technology to their breast center and patients.
GE estimates that by 2020, more than 1 million women worldwide will be examined using SenoBright and this will positively impact the diagnosis results for nearly 250,000 women. SenoBright empowers clinicians to improve care pathways, increase efficiency, and control costs.
* Trademark of General Electric Company
GE Healthcare recently celebrated the first U.S. commercial installation of SenoBright* at Pink Lotus Breast Center (PLBC) in Beverly Hills, CA.